Request for Covid-19 Impact Assessment of this Report

Healthcare

United States Moxifloxacin HCl Market Report 2017

  • QYR1655597
  • 116 Pages
  • September 2017
  • Healthcare
Download Sample    Get Discount   
 
In this report, the United States Moxifloxacin HCl market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Moxifloxacin HCl in these regions, from 2012 to 2022 (forecast).

United States Moxifloxacin HCl market competition by top manufacturers/players, with Moxifloxacin HCl sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Bayer

Rivopharm

Actavis UK

MERCK

Cayman

Allergan

Tecoland

BOC Sciences

Aurobindo

NIVIKA Chemo Pharma

Neuland

HETERO

Xinchang Pharmaceutical

Jiangsu Yongda Pharmaceutical

HEC Pharm

Pioneer Biotech

Second Pharma

Chenmei

Bodyguard Pharmaceutical

Yutian Pharmaceutical

Shenyang J& Health

Easton Pharmaceutical

Yancheng Yufeng

YOKO

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Qualified Grade: 98.0%-99.5%

First Grade: 99.5-99.9%

Excellence Grade: ? 99.9%

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Moxifloxacin HCl for each application, including

Oral Tablets

Injection

Ophthalmic Drugs

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Moxifloxacin HCl Market Report 2017

1 Moxifloxacin HCl Overview

1.1 Product Overview and Scope of Moxifloxacin HCl

1.2 Classification of Moxifloxacin HCl by Product Category

1.2.1 United States Moxifloxacin HCl Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Moxifloxacin HCl Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Qualified Grade: 98.0%-99.5%

1.2.4 First Grade: 99.5-99.9%

1.2.5 Excellence Grade: ? 99.9%

1.3 United States Moxifloxacin HCl Market by Application/End Users

1.3.1 United States Moxifloxacin HCl Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Oral Tablets

1.3.3 Injection

1.3.4 Ophthalmic Drugs

1.4 United States Moxifloxacin HCl Market by Region

1.4.1 United States Moxifloxacin HCl Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Moxifloxacin HCl Status and Prospect (2012-2022)

1.4.3 Southwest Moxifloxacin HCl Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Moxifloxacin HCl Status and Prospect (2012-2022)

1.4.5 New England Moxifloxacin HCl Status and Prospect (2012-2022)

1.4.6 The South Moxifloxacin HCl Status and Prospect (2012-2022)

1.4.7 The Midwest Moxifloxacin HCl Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Moxifloxacin HCl (2012-2022)

1.5.1 United States Moxifloxacin HCl Sales and Growth Rate (2012-2022)

1.5.2 United States Moxifloxacin HCl Revenue and Growth Rate (2012-2022)

2 United States Moxifloxacin HCl Market Competition by Players/Suppliers

2.1 United States Moxifloxacin HCl Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Moxifloxacin HCl Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Moxifloxacin HCl Average Price by Players/Suppliers (2012-2017)

2.4 United States Moxifloxacin HCl Market Competitive Situation and Trends

2.4.1 United States Moxifloxacin HCl Market Concentration Rate

2.4.2 United States Moxifloxacin HCl Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Moxifloxacin HCl Manufacturing Base Distribution, Sales Area, Product Type

3 United States Moxifloxacin HCl Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Moxifloxacin HCl Sales and Market Share by Region (2012-2017)

3.2 United States Moxifloxacin HCl Revenue and Market Share by Region (2012-2017)

3.3 United States Moxifloxacin HCl Price by Region (2012-2017)

4 United States Moxifloxacin HCl Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Moxifloxacin HCl Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Moxifloxacin HCl Revenue and Market Share by Type (2012-2017)

4.3 United States Moxifloxacin HCl Price by Type (2012-2017)

4.4 United States Moxifloxacin HCl Sales Growth Rate by Type (2012-2017)

5 United States Moxifloxacin HCl Sales (Volume) by Application (2012-2017)

5.1 United States Moxifloxacin HCl Sales and Market Share by Application (2012-2017)

5.2 United States Moxifloxacin HCl Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Moxifloxacin HCl Players/Suppliers Profiles and Sales Data

6.1 Bayer

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Moxifloxacin HCl Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Bayer Moxifloxacin HCl Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Rivopharm

6.2.2 Moxifloxacin HCl Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Rivopharm Moxifloxacin HCl Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Actavis UK

6.3.2 Moxifloxacin HCl Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Actavis UK Moxifloxacin HCl Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 MERCK

6.4.2 Moxifloxacin HCl Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 MERCK Moxifloxacin HCl Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Cayman

6.5.2 Moxifloxacin HCl Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Cayman Moxifloxacin HCl Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Allergan

6.6.2 Moxifloxacin HCl Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Allergan Moxifloxacin HCl Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Tecoland

6.7.2 Moxifloxacin HCl Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Tecoland Moxifloxacin HCl Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 BOC Sciences

6.8.2 Moxifloxacin HCl Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 BOC Sciences Moxifloxacin HCl Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Aurobindo

6.9.2 Moxifloxacin HCl Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Aurobindo Moxifloxacin HCl Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 NIVIKA Chemo Pharma

6.10.2 Moxifloxacin HCl Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 NIVIKA Chemo Pharma Moxifloxacin HCl Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Neuland

6.12 HETERO

6.13 Xinchang Pharmaceutical

6.14 Jiangsu Yongda Pharmaceutical

6.15 HEC Pharm

6.16 Pioneer Biotech

6.17 Second Pharma

6.18 Chenmei

6.19 Bodyguard Pharmaceutical

6.20 Yutian Pharmaceutical

6.21 Shenyang J& Health

6.22 Easton Pharmaceutical

6.23 Yancheng Yufeng

6.24 YOKO

7 Moxifloxacin HCl Manufacturing Cost Analysis

7.1 Moxifloxacin HCl Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Moxifloxacin HCl

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Moxifloxacin HCl Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Moxifloxacin HCl Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Moxifloxacin HCl Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Moxifloxacin HCl Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Moxifloxacin HCl Sales Volume Forecast by Type (2017-2022)

11.3 United States Moxifloxacin HCl Sales Volume Forecast by Application (2017-2022)

11.4 United States Moxifloxacin HCl Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Moxifloxacin HCl

Figure United States Moxifloxacin HCl Market Size (K MT) by Type (2012-2022)

Figure United States Moxifloxacin HCl Sales Volume Market Share by Type (Product Category) in 2016

Figure Qualified Grade: 98.0%-99.5% Product Picture

Figure First Grade: 99.5-99.9% Product Picture

Figure Excellence Grade: ? 99.9% Product Picture

Figure United States Moxifloxacin HCl Market Size (K MT) by Application (2012-2022)

Figure United States Sales Market Share of Moxifloxacin HCl by Application in 2016

Figure Oral Tablets Examples

Table Key Downstream Customer in Oral Tablets

Figure Injection Examples

Table Key Downstream Customer in Injection

Figure Ophthalmic Drugs Examples

Table Key Downstream Customer in Ophthalmic Drugs

Figure United States Moxifloxacin HCl Market Size (Million USD) by Region (2012-2022)

Figure The West Moxifloxacin HCl Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Moxifloxacin HCl Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Moxifloxacin HCl Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Moxifloxacin HCl Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Moxifloxacin HCl Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Moxifloxacin HCl Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Moxifloxacin HCl Sales (K MT) and Growth Rate (2012-2022)

Figure United States Moxifloxacin HCl Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Moxifloxacin HCl Market Major Players Product Sales Volume (K MT) (2012-2017)

Table United States Moxifloxacin HCl Sales (K MT) of Key Players/Suppliers (2012-2017)

Table United States Moxifloxacin HCl Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Moxifloxacin HCl Sales Share by Players/Suppliers

Figure 2017 United States Moxifloxacin HCl Sales Share by Players/Suppliers

Figure United States Moxifloxacin HCl Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Moxifloxacin HCl Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Moxifloxacin HCl Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Moxifloxacin HCl Revenue Share by Players/Suppliers

Figure 2017 United States Moxifloxacin HCl Revenue Share by Players/Suppliers

Table United States Market Moxifloxacin HCl Average Price (USD/MT) of Key Players/Suppliers (2012-2017)

Figure United States Market Moxifloxacin HCl Average Price (USD/MT) of Key Players/Suppliers in 2016

Figure United States Moxifloxacin HCl Market Share of Top 3 Players/Suppliers

Figure United States Moxifloxacin HCl Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Moxifloxacin HCl Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Moxifloxacin HCl Product Category

Table United States Moxifloxacin HCl Sales (K MT) by Region (2012-2017)

Table United States Moxifloxacin HCl Sales Share by Region (2012-2017)

Figure United States Moxifloxacin HCl Sales Share by Region (2012-2017)

Figure United States Moxifloxacin HCl Sales Market Share by Region in 2016

Table United States Moxifloxacin HCl Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Moxifloxacin HCl Revenue Share by Region (2012-2017)

Figure United States Moxifloxacin HCl Revenue Market Share by Region (2012-2017)

Figure United States Moxifloxacin HCl Revenue Market Share by Region in 2016

Table United States Moxifloxacin HCl Price (USD/MT) by Region (2012-2017)

Table United States Moxifloxacin HCl Sales (K MT) by Type (2012-2017)

Table United States Moxifloxacin HCl Sales Share by Type (2012-2017)

Figure United States Moxifloxacin HCl Sales Share by Type (2012-2017)

Figure United States Moxifloxacin HCl Sales Market Share by Type in 2016

Table United States Moxifloxacin HCl Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Moxifloxacin HCl Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Moxifloxacin HCl by Type (2012-2017)

Figure Revenue Market Share of Moxifloxacin HCl by Type in 2016

Table United States Moxifloxacin HCl Price (USD/MT) by Types (2012-2017)

Figure United States Moxifloxacin HCl Sales Growth Rate by Type (2012-2017)

Table United States Moxifloxacin HCl Sales (K MT) by Application (2012-2017)

Table United States Moxifloxacin HCl Sales Market Share by Application (2012-2017)

Figure United States Moxifloxacin HCl Sales Market Share by Application (2012-2017)

Figure United States Moxifloxacin HCl Sales Market Share by Application in 2016

Table United States Moxifloxacin HCl Sales Growth Rate by Application (2012-2017)

Figure United States Moxifloxacin HCl Sales Growth Rate by Application (2012-2017)

Table Bayer Basic Information List

Table Bayer Moxifloxacin HCl Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Bayer Moxifloxacin HCl Sales Growth Rate (2012-2017)

Figure Bayer Moxifloxacin HCl Sales Market Share in United States (2012-2017)

Figure Bayer Moxifloxacin HCl Revenue Market Share in United States (2012-2017)

Table Rivopharm Basic Information List

Table Rivopharm Moxifloxacin HCl Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Rivopharm Moxifloxacin HCl Sales Growth Rate (2012-2017)

Figure Rivopharm Moxifloxacin HCl Sales Market Share in United States (2012-2017)

Figure Rivopharm Moxifloxacin HCl Revenue Market Share in United States (2012-2017)

Table Actavis UK Basic Information List

Table Actavis UK Moxifloxacin HCl Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Actavis UK Moxifloxacin HCl Sales Growth Rate (2012-2017)

Figure Actavis UK Moxifloxacin HCl Sales Market Share in United States (2012-2017)

Figure Actavis UK Moxifloxacin HCl Revenue Market Share in United States (2012-2017)

Table MERCK Basic Information List

Table MERCK Moxifloxacin HCl Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure MERCK Moxifloxacin HCl Sales Growth Rate (2012-2017)

Figure MERCK Moxifloxacin HCl Sales Market Share in United States (2012-2017)

Figure MERCK Moxifloxacin HCl Revenue Market Share in United States (2012-2017)

Table Cayman Basic Information List

Table Cayman Moxifloxacin HCl Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Cayman Moxifloxacin HCl Sales Growth Rate (2012-2017)

Figure Cayman Moxifloxacin HCl Sales Market Share in United States (2012-2017)

Figure Cayman Moxifloxacin HCl Revenue Market Share in United States (2012-2017)

Table Allergan Basic Information List

Table Allergan Moxifloxacin HCl Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Allergan Moxifloxacin HCl Sales Growth Rate (2012-2017)

Figure Allergan Moxifloxacin HCl Sales Market Share in United States (2012-2017)

Figure Allergan Moxifloxacin HCl Revenue Market Share in United States (2012-2017)

Table Tecoland Basic Information List

Table Tecoland Moxifloxacin HCl Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Tecoland Moxifloxacin HCl Sales Growth Rate (2012-2017)

Figure Tecoland Moxifloxacin HCl Sales Market Share in United States (2012-2017)

Figure Tecoland Moxifloxacin HCl Revenue Market Share in United States (2012-2017)

Table BOC Sciences Basic Information List

Table BOC Sciences Moxifloxacin HCl Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure BOC Sciences Moxifloxacin HCl Sales Growth Rate (2012-2017)

Figure BOC Sciences Moxifloxacin HCl Sales Market Share in United States (2012-2017)

Figure BOC Sciences Moxifloxacin HCl Revenue Market Share in United States (2012-2017)

Table Aurobindo Basic Information List

Table Aurobindo Moxifloxacin HCl Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Aurobindo Moxifloxacin HCl Sales Growth Rate (2012-2017)

Figure Aurobindo Moxifloxacin HCl Sales Market Share in United States (2012-2017)

Figure Aurobindo Moxifloxacin HCl Revenue Market Share in United States (2012-2017)

Table NIVIKA Chemo Pharma Basic Information List

Table NIVIKA Chemo Pharma Moxifloxacin HCl Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure NIVIKA Chemo Pharma Moxifloxacin HCl Sales Growth Rate (2012-2017)

Figure NIVIKA Chemo Pharma Moxifloxacin HCl Sales Market Share in United States (2012-2017)

Figure NIVIKA Chemo Pharma Moxifloxacin HCl Revenue Market Share in United States (2012-2017)

Table Neuland Basic Information List

Table HETERO Basic Information List

Table Xinchang Pharmaceutical Basic Information List

Table Jiangsu Yongda Pharmaceutical Basic Information List

Table HEC Pharm Basic Information List

Table Pioneer Biotech Basic Information List

Table Second Pharma Basic Information List

Table Chenmei Basic Information List

Table Bodyguard Pharmaceutical Basic Information List

Table Yutian Pharmaceutical Basic Information List

Table Shenyang J& Health Basic Information List

Table Easton Pharmaceutical Basic Information List

Table Yancheng Yufeng Basic Information List

Table YOKO Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Moxifloxacin HCl

Figure Manufacturing Process Analysis of Moxifloxacin HCl

Figure Moxifloxacin HCl Industrial Chain Analysis

Table Raw Materials Sources of Moxifloxacin HCl Major Players/Suppliers in 2016

Table Major Buyers of Moxifloxacin HCl

Table Distributors/Traders List

Figure United States Moxifloxacin HCl Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure United States Moxifloxacin HCl Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Moxifloxacin HCl Price (USD/MT) Trend Forecast (2017-2022)

Table United States Moxifloxacin HCl Sales Volume (K MT) Forecast by Type (2017-2022)

Figure United States Moxifloxacin HCl Sales Volume (K MT) Forecast by Type (2017-2022)

Figure United States Moxifloxacin HCl Sales Volume (K MT) Forecast by Type in 2022

Table United States Moxifloxacin HCl Sales Volume (K MT) Forecast by Application (2017-2022)

Figure United States Moxifloxacin HCl Sales Volume (K MT) Forecast by Application (2017-2022)

Figure United States Moxifloxacin HCl Sales Volume (K MT) Forecast by Application in 2022

Table United States Moxifloxacin HCl Sales Volume (K MT) Forecast by Region (2017-2022)

Table United States Moxifloxacin HCl Sales Volume Share Forecast by Region (2017-2022)

Figure United States Moxifloxacin HCl Sales Volume Share Forecast by Region (2017-2022)

Figure United States Moxifloxacin HCl Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370